BOSSRA
IDXX icon

B.O.S.S. Retirement Advisors’s Idexx Laboratories IDXX Stock Holding History

B.O.S.S. Retirement Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300K Sell
569
-239
-30% -$134K 0.08% 129
2026
Q1 		$454K Sell
808
-392
-33% -$251K 0.14% 100
2025
Q4 		$812K Sell
1,200
-1,915
-61% -$1.3M 0.26% 72
2025
Q3 		$1.99M Sell
3,115
-434
-12% -$263K 0.48% 50
2025
Q2 		$1.9M Sell
3,549
-257
-7% -$123K 0.48% 41
2025
Q1 		$1.6M Sell
3,806
-272
-7% -$118K 0.46% 47
2024
Q4 		$1.69M Buy
+4,078
New +$1.79M 0.47% 49
2024
Q1 		– Sell
-4,854
Closed -$2.69M – 174
2023
Q4 		$2.69M Sell
4,854
-118
-2% -$55.4K 0.52% 51
2023
Q3 		$2.17M Buy
4,972
+201
+4% +$100K 0.47% 64
2023
Q2 		$2.4M Buy
4,771
+168
+4% +$80.5K 0.51% 51
2023
Q1 		$2.3M Buy
4,603
+313
+7% +$150K 0.54% 54
2022
Q4 		$1.75M Buy
+4,290
New +$1.67M 0.45% 92

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

B.O.S.S. Retirement Advisors's IDXX Position: Q2 2026 in Review

B.O.S.S. Retirement Advisors reduced its Idexx Laboratories (IDXX) stake by 30% in Q2 2026, selling an estimated $134K and leaving 569 shares worth $300K. The position accounts for 0.08% of the portfolio, ranked #129.

B.O.S.S. Retirement Advisors first reported a position in IDXX in Q4 2022 and has held it in 12 quarters since. The position peaked at $2.69M in Q4 2023. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • B.O.S.S. Retirement Advisors held 569 shares of Idexx Laboratories worth $300K as of Q2 2026.
  • B.O.S.S. Retirement Advisors sold 239 Idexx Laboratories shares in Q2 2026, an estimated $134K.
  • Idexx Laboratories made up 0.08% of B.O.S.S. Retirement Advisors's portfolio in Q2 2026, its #129 holding.
  • B.O.S.S. Retirement Advisors first reported a position in Idexx Laboratories in Q4 2022 and has held it in 12 quarters since.
  • B.O.S.S. Retirement Advisors's Idexx Laboratories position peaked at $2.69M in Q4 2023.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on B.O.S.S. Retirement Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.